Journal of Labor and Childbirth

Review Article - Journal of Labor and Childbirth (2023) Volume 6, Issue 3

Syndrome of Miscarriage: Linking Obstetric and Age Related Disorders to Early Labor

Emma Bourne*

Department of Gynecology, University of Milan, Italy

 

*Corresponding Author:
Emma Bourne
Department of Gynecology, University of Milan, Italy
E-mail: bournea@um.ac.it

 

Received: 01-June-2023, Manuscript No.jlcb-23-102621;Editor assigned: 05-June-2023, Pre QC No. jlcb- 23-102621 PQ); Reviewed: 19- June-2023, QC No. jlcb-23-102621; Revised: 22-June-2023, Manuscript No. jlcb-23-102621(R); Published: 29-June-2023; DOI: 10.37532/ jlcb.2023.6(3).084-086

Abstract

The uterine mucosa, or endometrium, transforms into a robust decidual matrix upon embryo implantation to accommodate the fetal placenta throughout pregnancy. The transformation of endometrial fibroblasts into specialized decidual cells is the driving force behind this change. For decidual homeostasis and expansion in early pregnancy, a coordinated influx of circulating natural killer (NK) cells and bone marrow-derived mesenchymal stem/progenitor cells (BM-MSC) is essential. We hypothesize that miscarriage is linked to subsequent adverse pregnancy outcomes, such as premature labor and loss of another pregnancy, by pathological signals that interfere with the recruitment or activity of extrauterine cells at the maternal-fetal interface. Recurrent miscarriage and age-related disorders, such as cardiometabolic disease, share a common aetiology because NK cells and BM-MSC are important homeostatic regulators in multiple tissues. We propose the term ‘unsuccessful labor condition’ to catch the wellbeing chances related with unnatural birth cycle.

The uterine mucosa, or endometrium, transforms into a robust decidual matrix upon embryo implantation to accommodate the fetal placenta throughout pregnancy. The transformation of endometrial fibroblasts into specialized decidual cells is the driving force behind this change. For decidual homeostasis and expansion in early pregnancy, a coordinated influx of circulating natural killer (NK) cells and bone marrow-derived mesenchymal stem/progenitor cells (BM-MSC) is essential. We hypothesize that miscarriage is linked to subsequent adverse pregnancy outcomes, such as premature labor and loss of another pregnancy, by pathological signals that interfere with the recruitment or activity of extrauterine cells at the maternal-fetal interface. Recurrent miscarriage and age-related disorders, such as cardiometabolic disease, share a common aetiology because NK cells and BM-MSC are important homeostatic regulators in multiple tissues. We propose the term ‘unsuccessful labor condition’ to catch the wellbeing chances related with unnatural birth cycle.

Keywords

Uterine mucosa • Endometrium• Robust decidual matrix• Bone Marrow Derived mesenchyme cell • Extra uterine cell • Cardio metabolic disease • Endometrial fibroblast

Introduction

Before or shortly after implantation, an estimated 60% of human embryos die. The ability of the endometrium to participate in embryo biosensing and selection as well as intrinsic chromosomal instability in preimplantation embryos account for this high attrition rate. Following implantation, the majority of pregnancy failures take place so quickly that they go unnoticed, while the remaining cases manifest as clinical miscarriages. There are 108%, 19%, and 07% of women in the general population who have selfreported having one, two, or more miscarriages. The first trimester of pregnancy is the time when over 90% of losses occur. The risk of miscarriage increases sharply after the age of 34 because of the exponential increase in chromosome error rates in oocytes and fetal tissues. Maternal age is a major factor in miscarriage rates. Regardless of the mother’s age, the risk of miscarriage rises incrementally by 79% with each additional loss. For instance, after one miscarriage at the age of 34, the likelihood of a live birth is 82%, after three losses, it is 68%, and after five losses, it is 50%.4 Although the majority of women who have recurrent miscarriages will go on to have a live birth, these pregnancies are at risk for preterm birth, fetal growth restriction, placental abruption, and stillbirth. The risk of obstetric disorders in an ongoing pregnancy in the future increases with each additional pregnancy loss. In later life, recurrent miscarriage is also associated with diabetes, hyperlipidemia, hypertension, and a fivefold increased risk of myocardial infarction. Compared to the general population, women who have experienced recurrent miscarriages are more likely than others to develop these diseases earlier in life. Ladies with a background marked by repetitive premature delivery display essentially higher 10 year cardiovascular gamble scores when contrasted with control subjects of the equivalent age [1].

Pathophysiology of miscarriage

The endometrium goes through iterative cycles of tissue repair and breakdown during the reproductive years. Progesterone-dependent differentiation follows oestrogen-dependent proliferation of resident epithelial and stromal cells in each ovulatory cycle, resulting in a four- day window for embryo implantation. The onset of the implantation window is marked by rapid remodeling of the stroma and glands. This process eventually leads to the breakdown of menstruation or, in the case of pregnancy, the formation of a strong matrix called the decidua that houses the placenta. Chemokine secretion and temporary tissue oedema encourage the influx of Natural Killer (NK) cells and Bone Marrow-Derived Mesenchymal Stem/progenitor (BM-MSC) innate immune cells. 1618 In parallel, when the window closes, stromal cells become decidual cells that are resistant to stress and dependent on progesterone. Some fibroblasts that are damaged by replication stress during the growth phase fail to differentiate and develop an acute senescence phenotype. The term “senescence” refers to an evolutionarily conserved cell state characterized by a complex Senescence-Associated Secretory Phenotype (SASP), permanent growth arrest, and resistance to apoptosis. The abundance of extracellular matrix proteins and proteases, chemokines, and inflammatory mediators that senescent endometrial fibroblasts secrete makes the environment conducive to implantation. Long-term SASP production causes secondary senescence in adjacent decidual cells, tissue inflammation, an influx of neutrophils, and menstrual breakdown, despite the fact that the number of these cells is initially small. After an embryo is successfully implanted, progesteronedependent decidual cells are maintained. These cells secrete interleukin-15 and other factors that instruct uterine NK cells to eliminate senescent fibroblasts to counteract the endometrial propensity for self-destruction. Additionally, differentiation of BM-MSC into distinct prolactin-producing decidual cells compensates for cell loss and promotes plasticity at the developing maternal-fetal interface [2, 3].

There are numerous reports in the literature that link abnormalities in the circulating NK and other immune cells to recurrent miscarriage. 31 However, there is insufficient agreement regarding the precise nature of immune cell dysfunctions or their effects on the maternalfetal interface. In addition, a significant Norwegian registry linkage study found that the majority of pre-existing chronic disorders, including autoimmune disorders, has little effect on miscarriage risk. Cardiovascular disease, specifically atherosclerosis, is a notable exception. 32 After implantation, invading trophoblasts block the decidual spiral arterioles, preventing the developing placenta from being perfused for the first 1012 weeks of pregnancy [4, 5]. 3336 As a result, transvascular migration of extrauterine cells in early pregnancy may be primarily affected by vasculitis. Uterine endothelial progenitors are also produced by BM-MSC, implying a connection between pre-existing cardiovascular disease and abnormal decidual transformation of the endometrium [6, 7]. The uteroplacental arteries become large fibrinoid vessels devoid of endothelium and other vessels as pregnancy progresses into the second trimester. This prevents extrauterine cells from entering the center of the placental bed. Accordingly, the level of pliancy of the maternal-fetal connection point may not just not set in stone in early growth, yet at the same homeostatic uneven characters underneath the limit for premature delivery could become enhanced past the subsequent trimester, driving to preterm work and other obstetric issues [8].

Implication of clinical research

Current meanings of intermittent premature delivery are based on an inconsistent number of pregnancy misfortunes, normally two or on the other hand three, and don’t catch the heightening gamble of Unfavorable wellbeing results with each extra pregnancy misfortune. 3 In order to inform women and guide healthcare professionals in determining the level of surveillance in subsequent pregnancies and beyond, we propose that individualized assessments of the risk of “miscarriage syndrome” should be included in clinical management of early pregnancy loss. Based on maternal age, the number and order of previous losses, as well as the number and sequence of live births, data from nationwide registry-based cohort studies already make it possible to count the general recurrence risk of miscarriage. 4 We propose that individualized predictions of health risks will be refined by including cardio metabolic disease risk factors like ethnicity, BMI, lifestyle factors, and laboratory tests. In a recent scientific statement, the American Heart Association (AHA) emphasized the significance of active interventions to reduce the risk of cardiovascular disease in the future in pregnancy affected by preeclampsia, preterm birth, or other obstetrical conditions. 42 In addition to recommending a heart-healthy diet and sufficient physical activity for the rest of one’s life, the American Heart Association also called for research into the effects of medication on primary cardiovascular disease following adverse pregnancy outcomes. The use of the term “miscarriage syndrome” will not only make these recommendations applicable to the treatment of miscarriage by medical professionals, but it will also probably increase patient compliance [9, 10].

Conclusion

In a nutshell, the massive recruitment of extrauterine BM-MSC and immune cells is a crucial factor in the plasticity and integrity of the maternal-fetal interface during pregnancy. According to our hypothesis, this dependence makes early pregnancy a “stress test” of a physiological system that is also essential for maintaining tissue homeostasis as we get older. Miscarriage may not only “unmask” a underlying defect, but it may also increase the likelihood of a defect with each subsequent loss. This explains why higher-order miscarriages increase the risk of obstetrical disorders and cardiometabolic disease in later life. It is essential to distinguish pregnancy failure from “miscarriage syndrome,” which necessitates enhanced surveillance and intervention to safeguard the health of babies and their mothers in subsequent pregnancies and beyond. Pregnancy failure can be an isolated event, such as caused by fetal aneuploidy.

References

  1. Wu CQ, Nichols K, Carwana M et al. Preterm birth after recurrent pregnancy loss: a systematic review and meta analysis. Fertil Steril. 117, 811-819 (2022).

    2. Indexed at, Google Scholar, Crossref

  2. Horn J, Tanz LJ, Stuart JJ et al. Early or late pregnancy loss and development of clinical cardiovascular disease risk factors: a prospective cohort study. BJOG. 126, 33-42 (2019).

    3. Indexed at, Google Scholar, Crossref

  3. Kharazmi E, Dossus L, Rohrmann S et al. Pregnancy loss and risk of cardiovascular disease: a prospective population-based cohort study (EPIC-Heidelberg). Heart. 97, 49-54 (2011).

    4. Indexed at, Google Scholar, Crossref

  4. Ranthe MF, Andersen EAW, Wohlfahrt J et al. Pregnancy loss and later risk of atherosclerotic disease. Circulation. 127, 1775-1782 (2013).

    5. Indexed at, Google Scholar, Crossref

  5. Wagner MM, Beshay MM, Rooijakkers S et al. Increased cardiovascular disease risk in women with a history of recurrent miscarriage. Acta Obstet Gynecol Scand. 97, 1192-1199 (2018).

    6. Indexed at, Google Scholar, Crossref

  6. Robbins CL, Hutchings Y, Dietz PM et al. History of preterm birth and subsequent cardiovascular disease: a systematic review. Am J Obstet Gynecol. 210, 285-297 (2014).

    7. Indexed at, Google Scholar, Crossref

  7. Smith GCS, Wood AM, Pell JP et al. Recurrent miscarriage is associated with a family history of ischaemic heart disease: a retrospective cohort study: Recurrent miscarriage and family history of IHD. BJOG. 118, 557-563 (2011).

    8. Indexed at, Google Scholar, Crossref

  8. Coomarasamy A, Gallos ID, Papadopoulou A et al. Sporadic miscarriage: evidence to provide effective care. Lancet. 397, 1668-1674 (2021).

    9. Indexed at, Google Scholar, Crossref

  9. Coomarasamy A, Dhillon-Smith RK, Papadopoulou A et al. Recurrent miscarriage: evidence to accelerate action. Lancet. 397, 1675-1682 (2021).

    10. Indexed at, Google Scholar, Crossref

  10. Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev. 35, 851-905 (2014).

    11. Indexed at, Google Scholar, Crossref